On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - The multi-center T-SPARCLE registry study
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
117
Journal Issue
9
Pages
814
Date Issued
2018-09
Author(s)
Tseng, Wei-Kung
Yin, Wei-Hsian
Li, Yi-Heng
Yeh, Hung-I
Chen, Jaw-Wen
the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators
Abstract
The aim of this study is to determine the relationship between the on-treatment lipid profiles and the CV events in CKD and non-CKD population.
Subjects
Cardiovascular disease; Chronic kidney disease; Lipid; Secondary prevention
SDGs
Other Subjects
acetylsalicylic acid; alanine aminotransferase; angiotensin receptor antagonist; aspartate aminotransferase; beta adrenergic receptor blocking agent; cholesterol; creatine kinase; dipeptidyl carboxypeptidase inhibitor; fibric acid derivative; high density lipoprotein cholesterol; hydroxymethylglutaryl coenzyme A reductase inhibitor; lipid; low density lipoprotein cholesterol; triacylglycerol; hydroxymethylglutaryl coenzyme A reductase inhibitor; hypocholesterolemic agent; low density lipoprotein cholesterol; adult; aged; alanine aminotransferase blood level; Article; aspartate aminotransferase blood level; body mass; brain ischemia; cardiovascular disease; cardiovascular risk; cholesterol blood level; chronic kidney failure; cigarette smoking; clinical outcome; comorbidity; congestive heart failure; coronary artery atherosclerosis; creatine kinase blood level; diabetes mellitus; female; heart failure; human; hypertension; major adverse cardiac event; major clinical study; male; medical history; multicenter study; observational study; peripheral occlusive artery disease; physical activity; prediction; recurrent disease; secondary prevention; smoking cessation; triacylglycerol blood level; atherosclerosis; blood; cardiovascular disease; chronic kidney failure; clinical trial; complication; incidence; middle aged; proportional hazards model; register; secondary prevention; Taiwan; very elderly; Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Proportional Hazards Models; Registries; Renal Insufficiency, Chronic; Secondary Prevention; Taiwan
Publisher
ELSEVIER TAIWAN